1. McEwen. Standard Treatment Programme. One-to-one smoking cessation support. NHS Centre for smoking Cessation and Training; 2011.
2. NCD-strategi 2013 – 2017 For forebygging, diagnostisering, behandling og rehabilitering av fire ikke-smittsomme folkesykdommer; hjerte- og karsykdommer, diabetes, kols og kreft. omsorgsdepartementet H-o; 2013. Tilgjengelig fra: https://www.regjeringen.no/no/dokumenter/ncd-strategi/id735195/
3. Statistisk sentralbyrå. Levekårsundersøkelsen 2008. Helse, omsorg og sosial kontakt. 2008. Tilgjengelig fra: http://www.ssb.no/emner/03/01/helseforhold/art-200...
4. Vollset SE. Hvor dødelig er røyking? : rapport om dødsfall og tapte leveår som skyldes røyking. 2006:4 utg. Oslo: Nasjonalt folkehelseinstitutt; 2006.
5. Lund, KE et al. Tobakksforbruket hos kvinner og menn 1927–2007. Tidsskr Nor Legeforen 2009;129:1871 – 4
6. Lindbak R, Helleve A. Tal om tobakk: 1973-2012. Oslo: Helsedirektoratet; 2013.
7. WHO. Evaluering av effektive strategier for tobakksforebygging i Norge. 2010.
8. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews 2008;(2):CD000165.
9. Zwar N, Richmond R, Borland R, Stillman S, Cunningham M, Litt J. Smoking cessation guidelines for Australian general practice. Australian Family Physician 2005;34(6):461-6.
10. NICE. Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women and hard to reach communities. NICE NIfHaCE; 2008, oppdatert 2013. Tilgjengelig fra: https://www.nice.org.uk/guidance/PH10
11.New Zealand Ministry of health. New Zealand Smoking Cessation Guidelines. 2007, oppdatert 2021. Tilgjengelig fra: https://www.health.govt.nz/system/files/documents/publications/the-new-zealand-guidelines-for-helping-people-to-stop-smoking-2021.pdf
12. Socialstyrelsen. Nationella riktlinjer för sjukdomsförebyggande metoder, 2011 - www.socialstyrelsen.se/nationellariktlinjerforsjukdomsforebyggandemetoder
13. Laitinen LA, Koskela K. Chronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998-2007. Respiratory Medicine 1999;93(5):297-332.
14. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews 2013;5:CD000165.
15. Tobaksavvänjing i hälso- och sjukvården. Folkhälsoinstitutet.; 2004.
16. North D, Barham P, Glasgow H, Glover M, Mac Lean D, Taylor S. Guidelines for Smoking Cessation. Commitee NH; 2002.
17. Lindson-Hawley N, Aveyard P, Hughes JR. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database of Systematic Reviews 2012;11:CD008033.
18. Cheong Y, Yong HH, Borland R. Does how you quit affect success? A comparison between abrupt and gradual methods using data from the International Tobacco Control Policy Evaluation Study. Nicotine and Tobacco Research 2007;9(8):801-10.
19. Lindson N, Aveyard P, Hughes JR. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database of Systematic Reviews.
22. Fiore MC JC, Baker TB,et al. Treating Tobacco Use and Dependence: 2008 Update. U.S. Department of Health and Human Services PHSM; 2008. http://www.ncbi.nlm.nih.gov/books/NBK63952/
23. Folkhälsoinstitutet. Det Motiverande Samtalet om Tobaksvanor. Tobak och avvänjing. Stockholm: Folkhälsoinstitutet; 2004.
24. Van Rensburg KJ, Taylor A, Hodgson T. The effects of acute exercise on attentional bias towards smoking-related stimuli during temporary abstinence from smoking. Addiction 2009;104(11):1910-7.
25. Nord. Nordic Nutrition Recommendations 2004. 4th edition. Nord 2004;13. 2004.
26. Tobacco Use: Prevention, Cessation, and Control. RTI International-University of North Carolina at Chapel Hill NCR-UE-bPCE; 2006. AHRQ Publication No. 06-E015.
27. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews 2005;(2):CD001007.
28. Lemmens V, Oenema A, Knut IK, Brug J. Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. European Journal of Cancer Prevention 2008;17(6):535-44.
29. Sæterdal IvM. Legemidler til røykeslutt. nr 8-2010 utg. Oslo: Nasjonalt kunnskapssenter for helsetjenesten; 2010.
30. Hagen G, Wisløff T, Klemp M. Cost-effectiveness of varenicline, bupropion and nicotinereplacement therapy for smoking cessation. nr 10-2010 utg. Oslo: Nasjonalt kunnskapssenter for helsetjenesten; 2010.
31. helsedirektoratet S-o. Røykeavvenning i primærhelsetjenesten: retningslinjer for primærhelsetjenestens arbeid med røykeavvenning. Oslo: Sosial- og helsedirektoratet; 2004.
32. Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database of Systematic Reviews 2012;10:CD008286.
33. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews 2013;5:CD009329.
34. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2012;11:CD000146.
35. U.S.Dept.of Health and Human Services PHS. Treating tobacco use and dependence: 2008 Update. Rockville, Md.: U.S. Dept. of Health and Human Services, Public Health Service; 2008.
36. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2014;1:CD000031.
37. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. [Update of Cochrane Database Syst Rev. 2011;(2):CD006103; PMID: 21328282]. 2012.
39. FOLKHÄLSOINSTITUT S. Tobak och avvänjning. En faktaskrift om tobakens skadeverkningar och behovet av tobaksavvänjning. folkhälsoinstitut S; 2010. R 2009:17. Tilgjengelig fra: https://www.yumpu.com/sv/document/view/20818560/tobak-och-avvanjning-101-mb-statens-folkhalsoinstitut
40. E vE, van der Meer RM, Reda AA, van Schayck CP, Kotz D. Smoking cessation in smokers with chronic obstructive pulmonary disease. Reviews ooS; 2013. 2013, Issue 9. Art.No.: CD010744. DOI: 10.1002/14651858.CD010744.
41. van der Meer RM, Wagena EJ, Ostelo RW, Jacobs JE, van Schayck CP. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2003;(2):CD002999.
42. Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respiratory Medicine 2011;105(3):477-84.
43. Tashkin DP, Rennard S, Hays JT, Ma W, Lawrence D, Lee TC. Effects of Varenicline on Smoking Cessation in Mild-to-Moderate COPD: A Randomized Controlled Trial. Chest 2010.
44. Medisinsk fødselsregister Mors røykevaner ved svangerskapets slutt 2014 http://statistikkbank.fhi.no/mfr/
45. Strandberg-Larsen K, Tinggaard M, Nybo Andersen AM, Olsen J, nbaek M. Use of nicotine replacement therapy during pregnancy and stillbirth: a cohort study. BJOG: An International Journal of Obstetrics and Gynaecology 2008;115(11):1405-10.
46. Hakonsen LB, Ernst A, Ramlau-Hansen CH. Maternal cigarette smoking during pregnancy and reproductive health in children: a review of epidemiological studies. Asian Journal of Andrology 2014;16(1):39-49.
47. Bowker KA LS, Coleman T,Vaz LR,Cooper S. Comparison of Cotinine Levels in Pregnant Women Whilst Smoking and When Using Nicotine Replacement Therapy. Nicotine Tob Res 2014.
48. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 2012;9:CD010078.
49. H S-N, T H. Zyban(R) (bupropion) og amming. Nor Farmaceut Tidsskr 2003;111(17).
50. Stanton A, Grimshaw G. Tobacco cessation interventions for young people. Cochrane Database of Systematic Reviews 2013;8:CD003289.
51. Ford CL, Zlabek JA. Nicotine replacement therapy and cardiovascular disease. Mayo Clinic Proceedings 2005;80(5):652-6.
52. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation 2010;121(2):221-9.
53. Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud AP, et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. European Heart Journal 2003;24(10):946-55.
54. Eisenberg MJ, Grandi SM, Gervais A, O'Loughlin J, Paradis G, Rinfret S, et al. Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial. Journal of the American College of Cardiology 2013;61(5):524-32.
55. Mills EJ, Thorlund K, Eapen S, Wu P, Prochaska JJ. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation 2014;129(1):28-41.
56. van der Meer RM, Willemsen MC, Smit F, Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database of Systematic Reviews 2013;8:CD006102.
57. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews 2013;2:CD007253.
58. Thomsen T, Villebro N, Moller AM. Interventions for preoperative smoking cessation. Cochrane Database of Systematic Reviews 2014;3:CD002294.
59. Lindstrom D, Sadr AO, Wladis A, Tonnesen H, Linder S, Nasell H, et al. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Annals of Surgery 2008;248(5):739-45.
60. Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA 2014;311(2):172-82.
61. Mackowick KM, Lynch MJ, Weinberger AH, George TP. Treatment of tobacco dependence in people with mental health and addictive disorders. Current Psychiatry Reports 2012;14(5):478-85.
62. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014;348:g1151.
63. McNeill A. Smoking and mental health: a review of the literature. health Aosa; 2001.
64. Campion J, Checinski K, Nurse J. Review of smoking cessation treatments for people with mental illness. Adv Psychiatr Treat 2008;(14):208-16.
65. Banham L, Gilbody S. Smoking cessation in severe mental illness: what works? Addiction 2010;105(7):1176-89.
66. Hitsman B, Moss TG, Montoya ID, George TP. Treatment of tobacco dependence in mental health and addictive disorders. Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie 2009;54(6):368-78.
67. Molden E, Spigset O. Tobacco smoking and drug interactions. Tidsskrift for Den Norske Laegeforening 2009;129(7):632-3.
68. Zwar N RR, Borland R, Peters M, Litt J, Bell J, Caldwell B,, I. F. Supporting smoking cessation: a guide for health professionals. Melbourne: The Royal Australian College of General Practitioners; 2011. Tilgjengelig fra: http://www.racgp.org.au/download/documents/Guideli...
69. Hughes JR. Tobacco withdrawal in self-quitters. Journal of Consulting and Clinical Psychology 1992;60(5):689-97.
70. Ussher MH, Taylor A, Faulkner G. Exercise interventions for smoking cessation. Cochrane Database of Systematic Reviews 2012;1:CD002295.
71. Winell K. Smoking, Nicotine Dependency and Interventions For Cessation. Practice. WgabtFAfG; 2003.
72. Sullivan LW. The health benefits of smoking cessation. A report of the Surgeon General. General. ArotS; 1990.
73. Farley AC, Hajek P, Lycett D, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database of Systematic Reviews 2012;1:CD006219.
74. Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ 2012;345:e4439.
75. Øverland S, Hetland J, Aarø, LE. Relative harm of snus and cigarettes: what do Norwegian adolescents say? Tobacco Control 2008;17(6):422-5.
76. Ot prp nr 67 (1995-96) Om lov om endringer i lov av 9. mars 1973 nr. 14 om vern mot tobakksskader. (1996).
77. SCENIHR. Health Effects of Smokeless Tobacco Products. Risks SCoEaNIH; 2008.
78. WHO. IARC Monographs on the Evaluation of Carcinogenic Risks to humans: smokeless tobacco and some tobaccospesific N-nitrosamines. Cancer IAfRo; 2007. volume 89.
79. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volum 100. IARC; 2012.
80. Folkehelseinstituttet. Helserisiko ved bruk av snus. 2014.
82. Sæterdal IvM, Harboe i, Ringerike T, Klemp M. Snusavvenningstiltak -systematisk litteratursøk med sortering. Notat 2012. Kunnskapssenteret; 2012.
83. Ebbert J, Montori VM, Erwin PJ, Stead LF. Interventions for smokeless tobacco use cessation. Cochrane database of systematic reviews 2011; 2 (pp CD004306)
84. Ebbert JO, Fagerstrom K. Pharmacological interventions for the treatment of smokeless tobacco use. CNS Drugs 2012;26(1):1-10.
85. Fagerström K, Gailljam H, Metcalf M, Tonstad S, Messig M. Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial. BMJ 2010;341(c6549).
86. Dybing E. Virkninger av snusbruk. nr 6-2005 utg. Oslo: Kunnskapssenteret; 2005.
87. Lund KE, McNeill A, Scheffels J. The use of snus for quitting smoking compared with medicinal products. Nicotine and Tobacco Research 2010;12(8):817-22.
88. Farsalinos KE, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, Voudris V. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Scientific reports 2014;4:4133.
89. Lund KE. Hva er elektroniske sigaretter, hvor farlige er de og hvordan bør de reguleres? Oslo: SIRUS; 2013. 5/2013.
90. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. The Cochrane database of systematic reviews 2014;12:CD010216.
91. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013;382(9905):1629-37.
92. Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 2014;109(11):1801-10.
93. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation 2014;129(19):1972-86.
94. Rahman MA, Hann, N. R., Wilson, A. M., Mnatzaganian, G., & Worrall-Carter, L. . Electronic Cigarettes Are Effective for Smoking Cessation: Evidence From a Systematic Review and Meta-analysis. Circulation 2014; 130((Suppl 2)): A14945-A.
95. En framtid uten tobakk. Nasjonal strategi for arbeidet mot tobakksskader
2013–2016. omsorgsdepartementet H-o; 2013.
96. West R. Getting Serious About Stopping Smoking - A Review of Products, Services and Techniques. A Report for No Smoking Day 1997. 1997.
97. Litt J, Ling MY, McAvoy B. How to help your patients quit: practice-based strategies for smoking cessation. Asia Pacific Fam Med 2003;(2):175-9.
98. U.S.Department of Heath and Human Services. Those who continue to smoke: is achieving abstinence harder and do we need to change our interventions? 15 utg. Washington D. C.: The Department; 2003.
99. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000;55(12):987-99.
100. Helsedirektoratet. Metodebok for utarbeidelse av nasjonale retningslinjer. Helsedirektoratet afkop; 2009.
101. Nasjonal strategi for det tobakksforebyggende arbeidet 2006-2010. [Oslo]: Helse- og omsorgsdepartementet; 2006.
102. Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA, Finland WGotAPi. Asthma programme in Finland: a community problem needs community solutions. Thorax 2001;56(10):806-14.
103. Stead M, Angus K, Holme I, Cohen D, Tait G, Team PER. Factors influencing European GPs' engagement in smoking cessation: a multi-country literature review. British Journal of General Practice 2009;59(566):682-90.
104. Thomas KH; Martin RM; Knipe DW; Higgins JP; Gunnell D. Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis. BMJ. 350:h1109, 2015.
105. Røyking og snusbruk i Noreg - Folkehelserapporten 2014, rapport 2014:4, utgiver Folkehelseinstituttet, ISBN 978-82-8082-635-0
106. Behandling af tobaksafhængighed – Anbefalinger til en styrket klinisk praksis. Sundhedsstyrelsen 2011; URL: http://www.sst.dk; http://sundhedsstyrelsen.dk/publ/Publ2011/BOFO/Tob...
107. Ebbert JO, Crogan IT, Severson HH, Schroeder DR, Hayes JT. A pilot study of the efficacy of varinicline for the treatment of smokeless Tobacco users in Midwest united States. Nicotine and Tobacco research 2011 13(9): 820-826.
108. Sæterdal I, Harboe I, Ringerike T, Klemp M. Snus som røykeavvenningsmiddel . Notat - Systematisk litteratursøk med sortering - 2012. ISBN 978-82-8121-487-3
109. Lindson-HawleyN,ThompsonTP, Begh R.Motivational interviewing for smoking cessation. CochraneDatabase of Systematic Reviews 2015, Issue 3. Art. No.: CD006936. DOI: 10.1002/14651858.CD006936.pub3.
110. 25 Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: a review. Addiction 2008; 104: 719-733.
111. Aubin, Henri-Jean, Farley, Amanda, Lycett, Deborah, Lahmek, Pierre, Aveyard, Paul (2012). Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ 2012;345:e4439. http://www.bmj.com/content/345/bmj.e4439
112. Karl Erik Lund og Tord Finne Vedøy (red.) SIRUS rapport 1/2015. Hvilken betydning har elektroniske sigaretter?- for røykeslutt, som inngangsport til røyking blant unge, for renormalisering av tobakksrøyking i samfunnet og som mulig inntaksmetode for narkotika
113. Helsedirektoratets plan for et systematisk og kunnskapsbasert tilbud om røyk- og snusavvenning, IS-2006, Helsedirektoratet, Oslo 2012
114. Hajek P, McRobbie H, Gillison F. Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user. Prev Med. 2007;44(3):230–234.
115. Shiffman S, Hughes JR, Di Marino ME, Sweeney CT. Patterns of over-the-counter nicotine gum use: persistent use and concurrent smoking. Addiction. 2003;98(12):1747–1753.
116. Anthenelli RM, Morris C,Ramey TS et al .Effects of varenicline on smoking cessation in adults with stably treated current or past major depression. Ann Intern Med. 2013;159:390–400.
117. Roberts E, Eden Evins A, McNeill A, Robson D. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis. Addiction. 2016 Apr; 111(4):599-612. Epub 2016 Jan 19.